A federal judge has stepped in to stop the Federal Trade Commission (FTC) from investigating two major medical organizations: the Endocrine Society and the World Professional Association for Transgender Health. Both groups support gender-affirming care for minors. The ruling, reported by Reuters via Yahoo! News, marks a significant legal development in the ongoing debate over transgender healthcare for young people.

What This Means for Patients and Families

For parents, doctors, and transgender youth, this ruling could affect access to care. Gender-affirming care includes treatments like puberty blockers and hormone therapy, which many medical experts say are safe and necessary for some adolescents. The Endocrine Society and WPATH have published clinical guidelines that doctors across the country rely on when treating transgender patients.

Medical organizations generally argue that these treatments follow evidence-based standards. However, the issue remains politically charged. Several states have passed laws restricting or banning gender-affirming care for minors, leading to a patchwork of regulations across the U.S.

Sanofi May Abandon FDA Priority Voucher for Type 1 Diabetes Drug Tzield

In another major health news story, drugmaker Sanofi is reportedly considering pulling its application for an FDA priority review voucher for teplizumab, sold under the brand name Tzield. The move comes after the FDA’s top regulator overruled a staff recommendation to expand the drug’s use in type 1 diabetes, according to Fierce Pharma.

Why This Matters for People With Type 1 Diabetes

Tzield is one of the few treatments that can delay the onset of type 1 diabetes in people at high risk. For patients and families, any delay in expanding access could mean fewer treatment options. Experts in endocrinology generally emphasize that early intervention is critical for managing type 1 diabetes and preventing complications.

Priority review vouchers are valuable tools that drug companies can use to speed up FDA review of other drugs. If Sanofi withdraws its application, it could slow down future treatments for other conditions as well.

FDA Says No Official Shortage of Estrogen Patches Despite Patient Reports

Despite widespread reports from patients who say they cannot fill their prescriptions, the FDA maintains there is no official shortage of estrogen patches. This news, reported by NBC News, has left many women confused and frustrated.

How This Affects Women in Menopause

Estrogen patches are commonly used by women going through menopause to manage symptoms like hot flashes, night sweats, and vaginal dryness. When patients cannot get their medication, it can disrupt their treatment and cause unnecessary suffering.

Pharmacists and healthcare providers often advise patients to call multiple pharmacies or ask their doctor about alternative forms of estrogen therapy, such as pills, creams, or vaginal rings. Experts also recommend checking with insurance companies about coverage for different brands.

New Study: Tirzepatide Shows Better Kidney Protection Than Dulaglutide

An exploratory analysis of the SURPASS-CVOT trial found that tirzepatide (Mounjaro) was linked to greater kidney protection compared with dulaglutide (Trulicity) in patients with type 2 diabetes and atherosclerotic cardiovascular disease. The findings were published in The Lancet Diabetes & Endocrinology.

What This Means for People With Diabetes and Heart Disease

For patients managing both type 2 diabetes and heart disease, protecting kidney function is a top priority. Kidney damage is a common complication of diabetes, and it can lead to dialysis or kidney transplant if not managed properly.

Doctors often prescribe GLP-1 receptor agonists like dulaglutide to help control blood sugar and reduce heart risks. Tirzepatide, which is a dual GIP and GLP-1 receptor agonist, may offer additional benefits for kidney health. Patients should talk to their healthcare provider about whether tirzepatide might be a good option for them.

Concerns Raised About Forever Chemicals and Phthalates in Infant Formula

Experts are raising alarms about the presence of forever chemicals and phthalates in the U.S. infant formula supply. The concerns come after a review of FDA data, as reported by The Guardian.

What Parents Should Know

Forever chemicals, also known as PFAS, and phthalates are industrial compounds that have been linked to various health problems, including hormone disruption and developmental issues. Infants are especially vulnerable because their bodies are still developing.

Pediatricians and public health experts generally recommend that parents choose infant formula from reputable brands and consider using filtered water for mixing. Some experts also suggest breastfeeding when possible, as breast milk typically contains fewer contaminants. However, formula feeding is a safe and necessary option for many families.

Study: Elite Female Athletes Have Higher Rates of XY Disorders of Sex Development

A study published in the Journal of Clinical Endocrinology & Metabolism found that elite female track and field athletes have a higher prevalence of XY disorders of sex development (DSD) compared to the general population. The research was based on serum sample analysis.

Understanding DSD and Its Impact on Sports

Disorders of sex development are rare conditions where a person’s chromosomes, hormones, or reproductive organs do not fit typical definitions of male or female. Having XY chromosomes but being raised as female is one example.

This topic has been controversial in sports, with debates about fairness and eligibility. Many medical experts say that DSD conditions are natural variations and that athletes should not be automatically excluded from competition. Sports governing bodies, including World Athletics, have specific rules about testosterone levels and eligibility for female events.

Amazon Pharmacy Now Offers Same-Day Delivery for Oral Semaglutide

Amazon Pharmacy has announced that it will offer same-day delivery or kiosk pick-up for oral semaglutide, sold under the brand name Ozempic, for type 2 diabetes. The news was reported by Fierce Healthcare.

Convenience for Diabetes Patients

For people with type 2 diabetes, getting medication quickly and reliably is essential. Same-day delivery through Amazon Pharmacy could make it easier for patients to stick to their treatment plans without worrying about running out of medication.

Oral semaglutide is a GLP-1 receptor agonist that helps control blood sugar and can also lead to weight loss. However, it is important to note that Ozempic is specifically approved for type 2 diabetes, not for weight loss alone. Patients should always consult their doctor before starting any new medication.

TV Shows Are Changing How They Portray Menopause

The New York Times recently reported a cultural shift in how modern television portrays menopause. Instead of treating it as a taboo subject or a punchline, more shows are depicting the real experiences of women going through this life stage.

Why Representation Matters

For decades, menopause was rarely discussed openly in media. This left many women feeling isolated or uninformed about what to expect. Accurate and respectful portrayals can help normalize the conversation and encourage women to seek medical advice when needed.

Healthcare providers generally recommend that women learn about menopause symptoms and treatment options, including hormone therapy, lifestyle changes, and non-hormonal medications. Open discussions with family, friends, and doctors can make the transition smoother.

European Regulators Approve First Clinical Trial for GLP-1 Gene Therapy

European regulators have given the green light for the first clinical trial of a beta cell-targeted GLP-1 gene therapy for type 2 diabetes. Fractyl Health announced the approval, which marks a potential breakthrough in diabetes treatment.

What Is Gene Therapy for Diabetes?

Gene therapy involves modifying a person’s genes to treat or prevent disease. In this case, the therapy targets beta cells in the pancreas, which are responsible for producing insulin. The goal is to help the body produce more GLP-1, a hormone that regulates blood sugar.

If successful, this approach could offer a long-term solution for people with type 2 diabetes, potentially reducing the need for daily injections or oral medications. However, clinical trials are still in early stages, and it may be years before this treatment becomes widely available.

Bariatric Surgery Changes Gut Bacteria Linked to Diabetes Remission

A subanalysis of a randomized trial published in Nature Metabolism found that patients who underwent bariatric surgery showed changes in their gut microbiome that were linked to type 2 diabetes remission.

How Weight Loss Surgery Affects Gut Health

The gut microbiome is the collection of bacteria and other microorganisms living in the digestive tract. Research shows that bariatric surgery can alter this microbiome in ways that improve metabolism and blood sugar control.

For people with obesity and type 2 diabetes, bariatric surgery can be a life-changing option. Many patients experience significant weight loss and even remission of diabetes. However, surgery is not without risks, and it requires lifelong dietary changes and medical follow-up.

Practical Takeaways for Readers

• Stay informed about medication availability: If you rely on estrogen patches or other medications that may face supply issues, talk to your pharmacist about alternatives.
• Monitor kidney health with diabetes: Ask your doctor about newer medications like tirzepatide that may offer kidney protection.
• Choose infant formula wisely: Look for brands that test for contaminants, and consider using filtered water for mixing.
• Talk openly about menopause: Don’t suffer in silence. Discuss symptoms and treatment options with your healthcare provider.
• Explore all diabetes treatment options: From oral medications to gene therapy trials, new treatments are on the horizon. Stay informed and ask your doctor what might work for you.

Source: MedPage Today